Please assess the completion status of the following clinical trial:

Trial Title: Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Morbid obesity~* Approved and scheduled for laparoscopic sleeve gastrectomy~Exclusion Criteria:~* Previous bariatric surgery~* Platelet count under 100,000~* Concurrent anticoagulation treatment~* Previous venous/atrerial thromboembolic event~* Known allergy to tranexamic acid~* History of heparin induced thrombocytopenia~* Oral contraceptive use~* Female hormonal replacement therapy~* Active thromboembolic state~* Genetic hypercoagulable state

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Treatment arm (Type: ACTIVE_COMPARATOR): Preoperative intravenous administration of 2g tranexamic acid in 10ml fluid.
- Control Arm (Type: PLACEBO_COMPARATOR): Preoperative intravenous administration of 10ml normal saline.

Based on this trial design, predict the completion outcome and termination type (if applicable).